Relative Bioavailability of Evobrutinib Tablet Batches
NCT07214922
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Treatment A
DRUG:
Treatment B
DRUG:
Treatment C
DRUG:
Treatment D
Sponsor
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany